The antibody drug benralizumab is on the fast track to becoming the first new treatment for certain kinds of asthma and COPD ...

A new injection, benralizumab, outperforms traditional steroids in treating asthma and COPD attacks, reducing treatment ...

Benralizumab is what’s known as a monoclonal antibody, which replicates properties of a normal antibody produced by the ...

Researchers at King's College London have found a new treatment for asthma attacks, which could be a 'game-changer' for the patients.

London scientists have created a “game-changing” new treatment for asthma attacks that can reduce the need for further ...

Benralizumab is already used in the most severe cases, but the latest research suggests it could be used routinely for around two million attacks in the UK each year ...

The IL-5 inhibitor is already available under the Fasenra brand name for maintenance use in severe eosinophilic asthma, but a ...

Every 30 seconds, someone in the world will experience a flare-up of their asthma or chronic obstructive pulmonary disease ...

The first new treatment for asthma attacks in 50 years may be a “game-changer”, researchers say. Offering patients an ...

Monoclonal antibody benralizumab was found to be more effective than the standard treatment in a clinical trial.

An injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, ...